Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-32,330
Closed -$2.41M 127
2021
Q4
$2.41M Hold
32,330
0.16% 76
2021
Q3
$1.52M Sell
32,330
-400
-1% -$17.4K 0.11% 83
2021
Q2
$1.32M Sell
32,730
-5,650
-15% -$234K 0.09% 93
2021
Q1
$1.58M Buy
+38,380
New +$1.43M 0.22% 60

Other funds holding ACLS

CSM Advisors's ACLS Position: Q1 2022 in Review

CSM Advisors sold out of Axcelis (ACLS) in Q1 2022, closing a stake of 32,330 shares — an estimated $2.41M sold.

CSM Advisors first reported a position in ACLS in Q1 2021 and held it in 4 quarters. The position peaked at $2.41M in Q4 2021. 290 funds tracked by Wall St. Rank hold ACLS as of Q1 2022.

  • CSM Advisors reported no remaining Axcelis position as of Q1 2022 after selling out during the quarter.
  • CSM Advisors sold 32,330 Axcelis shares in Q1 2022, an estimated $2.41M.
  • CSM Advisors first reported a position in Axcelis in Q1 2021 and held it in 4 quarters.
  • CSM Advisors's Axcelis position peaked at $2.41M in Q4 2021.
  • 290 funds tracked by Wall St. Rank held Axcelis as of Q1 2022.

Based on CSM Advisors's 13F filing for Q1 2022, filed 16 May 2022.